SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 73 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $12,423 | +73.8% | 12,941 | +35.8% | 0.00% | – |
Q1 2023 | $7,146 | +264.2% | 9,526 | +78.9% | 0.00% | – |
Q4 2022 | $1,962 | – | 5,325 | +541.6% | 0.00% | – |
Q3 2022 | $0 | -100.0% | 830 | -74.9% | 0.00% | – |
Q2 2022 | $2,000 | -50.0% | 3,302 | +10.8% | 0.00% | – |
Q1 2022 | $4,000 | – | 2,981 | +298000.0% | 0.00% | – |
Q3 2021 | $0 | – | 1 | -98.3% | 0.00% | – |
Q2 2021 | $0 | – | 58 | +31.8% | 0.00% | – |
Q1 2021 | $0 | – | 44 | -12.0% | 0.00% | – |
Q4 2020 | $0 | -100.0% | 50 | -98.8% | 0.00% | – |
Q2 2020 | $14,000 | -89.1% | 4,000 | -92.7% | 0.00% | – |
Q1 2020 | $128,000 | -97.5% | 55,103 | -96.0% | 0.00% | -100.0% |
Q4 2019 | $5,065,000 | -70.5% | 1,391,704 | -32.7% | 0.00% | -50.0% |
Q3 2019 | $17,151,000 | -3.7% | 2,067,603 | -0.0% | 0.00% | 0.0% |
Q2 2019 | $17,804,000 | -22.0% | 2,067,803 | -3.2% | 0.00% | -33.3% |
Q1 2019 | $22,838,000 | -23.5% | 2,136,351 | -37.4% | 0.00% | -25.0% |
Q4 2018 | $29,837,000 | -52.2% | 3,410,002 | -8.2% | 0.00% | -42.9% |
Q3 2018 | $62,418,000 | -50.8% | 3,715,416 | -38.6% | 0.01% | -53.3% |
Q2 2018 | $126,748,000 | +7.2% | 6,047,104 | -17.7% | 0.02% | +7.1% |
Q1 2018 | $118,193,000 | -11.4% | 7,345,693 | +4.4% | 0.01% | -12.5% |
Q4 2017 | $133,326,000 | +178.2% | 7,035,678 | +106.6% | 0.02% | +166.7% |
Q3 2017 | $47,916,000 | +407.5% | 3,405,489 | +168.7% | 0.01% | +500.0% |
Q2 2017 | $9,442,000 | +11.1% | 1,267,347 | -3.0% | 0.00% | 0.0% |
Q1 2017 | $8,496,000 | +38.6% | 1,307,147 | -5.5% | 0.00% | 0.0% |
Q4 2016 | $6,129,000 | -68.9% | 1,383,447 | -67.3% | 0.00% | -66.7% |
Q3 2016 | $19,737,000 | -29.2% | 4,226,322 | -0.4% | 0.00% | -25.0% |
Q2 2016 | $27,871,000 | +3.3% | 4,242,147 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $26,980,000 | +5.5% | 4,242,147 | 0.0% | 0.00% | +33.3% |
Q4 2015 | $25,580,000 | +0.8% | 4,242,147 | 0.0% | 0.00% | -25.0% |
Q3 2015 | $25,368,000 | -12.6% | 4,242,147 | 0.0% | 0.00% | 0.0% |
Q2 2015 | $29,016,000 | +12.7% | 4,242,147 | 0.0% | 0.00% | +33.3% |
Q1 2015 | $25,750,000 | -12.4% | 4,242,147 | 0.0% | 0.00% | -25.0% |
Q4 2014 | $29,398,000 | -14.9% | 4,242,147 | 0.0% | 0.00% | -20.0% |
Q3 2014 | $34,531,000 | +0.1% | 4,242,147 | 0.0% | 0.01% | 0.0% |
Q2 2014 | $34,489,000 | -4.1% | 4,242,147 | -7.5% | 0.01% | 0.0% |
Q1 2014 | $35,963,000 | -32.7% | 4,587,147 | -24.0% | 0.01% | -37.5% |
Q4 2013 | $53,410,000 | +3.2% | 6,035,047 | -2.1% | 0.01% | 0.0% |
Q3 2013 | $51,739,000 | +11.2% | 6,166,792 | -1.2% | 0.01% | 0.0% |
Q2 2013 | $46,541,000 | – | 6,238,680 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 6,963,756 | $145,960,000 | 9.42% |
Avoro Capital Advisors LLC | 3,419,818 | $71,679,000 | 2.76% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 300,000 | $6,285,000 | 2.41% |
Cormorant Asset Management, LP | 1,200,000 | $25,152,000 | 1.86% |
Sio Capital Management, LLC | 143,550 | $3,009,000 | 1.66% |
ASHFORD CAPITAL MANAGEMENT INC | 425,702 | $8,923,000 | 1.18% |
PURA VIDA INVESTMENTS, LLC | 130,700 | $2,739,000 | 1.10% |
Sonora Investment Management, LLC | 298,967 | $6,266,000 | 0.97% |
PURA VIDA INVESTMENTS, LLC | 100,000 | $2,096,000 | 0.84% |
J. Goldman & Co LP | 694,338 | $14,553,000 | 0.75% |